SHC
Sotera Health CompanyPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #827
- Final score
- 27.59
- Years on list
- 6
↘ Down 344 since 2021
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 344 since 2021
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 34 since 2023
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 140 since 2020
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | SHC | MEDP | BRKR |
|---|---|---|---|
| Climate Change | 21.7 | 34.8 | 28.0 |
| Employee Relations | 35.9 | 35.2 | 19.3 |
| Environment | 19.2 | 13.4 | 23.7 |
| Stakeholders & Society | 17.0 | 18.3 | 22.6 |
| Human Rights | 44.6 | 21.6 | 32.7 |
| Governance | 25.6 | 40.3 | 27.1 |
| Performance Rating | 49.2 | 48.4 | 37.9 |